Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to

Donald M Kuhn1, Dina M Francescutti-Verbeem, David M Thomas

  • 1John D. Dingell VA Medical Center, Research & Development Service (11R), 4646 John R, Detroit, MI 48201, USA. donald.kuhn@wayne.edu

Insights

Methamphetamine neurotoxicity involves dopamine-quinone species activating microglia. This activation alters gene expression, potentially amplifying damage to dopamine nerve endings in the brain.

Area of Science:

  • Neuroscience
  • Toxicology
  • Neuroinflammation

Background:

  • Methamphetamine (METH) intoxication causes persistent damage to dopamine (DA) nerve endings.
  • Microglial activation is implicated in METH-induced neurotoxicity.
  • Dopamine (DA) plays a role in METH neurotoxicity, possibly via quinone formation.

Purpose of the Study:

  • To investigate the role of dopamine-quinones (DAQ) in microglial activation.
  • To analyze the impact of DAQ on microglial gene expression.

Main Methods:

  • Cultured microglial cells were treated with DAQ.
  • Microarray analysis was used to assess changes in microglial gene expression.

Main Results:

  • DAQ induced time-dependent activation of microglial cells.
  • 101 genes were significantly altered in expression by DAQ (73 increased, 28 decreased).
  • Upregulated genes included those related to inflammation; downregulated genes included those associated with neuronal protection.

Conclusions:

  • DAQ contributes to early microglial activation in METH intoxication.
  • DAQ alters the expression of a broad panel of genes in microglia.
  • This study links oxidative stress, DA conversion to DAQ, and microglial activation in a cascade amplifying METH neurotoxicity.

Related Concept Videos

Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Neurochemical Transmission: Sites of Drug Action01:26

Neurochemical Transmission: Sites of Drug Action

Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...